Kindergartens and schools reopen after outbreak in Jutland town
Local restrictions were put into place in South Jutland town Kolding last month after an outbreak of the infectious B117 coronavirus variant was detected at schools and kindergartens.
The outbreak is now under relative control, with Kolding now the municipality with the seventh-highest infection rate nationally (141.9 per 100,000 residents over the last 7 days), having been the highest.
Children up to fourth grade can now return to school in the town and kindergartens can reopen, but authorities are still encouraging tests.
Ishøj west of Copenhagen currently has the highest infection rate in Denmark, followed by Fredensborg in northeastern Zealand.
Danish navy transports vaccines to remote parts of Greenland
Denmark’s military has started delivering Covid vaccines to remote settlements along Greenland’s west coast, news wire AFP reported this weekend.
The mission, which began in February, is part of efforts to vaccinate isolated communities in the vast territory where logistics are complicated by extreme cold weather.
We’ll have more detail in an article later today.
Permanent speedchecks to be set up on Great Belt and Øresund bridges
Permanent speed cameras will be set up from next year on the Great Belt Bridge, the 18-kilometre long fixed link connecting Zealand with Funen. The equally-impressive Øresund Bridge, which crosses from Copenhagen to Malmö in Sweden, will get the same treatment, the Ministry of Transport said in a statement.
The speed cameras will measure the average speed of motorists on sections of the bridges.
A law change will be required to enable to cameras to be fixed in place, but that is expected to be a formality and the equipment has already been ordered, according to news wire Ritzau.
Danish Covid-19 vaccine ready for clinical trials
Danish pharma company Bavarian Nordic is ready to test its potential Covid-19 vaccine on people, the company said in a stock market announcement.
The candidate vaccine, ABNCoV2 has shown efficacy against the virus and against long term effects of the disease in pre-clinical tests. It will now undergo clinical trials in the Netherlands.
Should it fare well in trials, the vaccine could be ready for general use in 2022.
Member comments